Immix Biopharma, Inc. (IMMX:NASDAQ) closed at $7.04 on November 19, 2026, down 0.98% on the day. The stock trades 53.4% below its 52-week high of $15.10 and 86.2% above its 52-week low of $3.78. Over the past year, it gained 62.6%. Immix Biopharma, Inc. is part of the Health Care sector.
In 252 trading sessions since November 19, 2025, IMMX closed higher on 123 days (49%). Its best day was December 4, 2025 (+16.63%) and its worst was March 18, 2026 (-14.93%). The stock moved 10% or more in a single session 15 times. It opened at least 5% above the previous day's high 1 time.
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.
Find more stocks like IMMX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.